Laura Grosse1,2, Livia A Carvalho3, Tom K Birkenhager4, Witte J Hoogendijk4, Steven A Kushner4, Hemmo A Drexhage5, Veerle Bergink4. 1. Department of Immunology, Erasmus Medical Center, Wijtemaweg 80, 3015CN, Rotterdam, The Netherlands. laura.grosse@ukmuenster.de. 2. Department of Psychiatry, University of Muenster, Muenster, Germany. laura.grosse@ukmuenster.de. 3. Department of Epidemiology and Public Health, University College London, London, UK. 4. Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands. 5. Department of Immunology, Erasmus Medical Center, Wijtemaweg 80, 3015CN, Rotterdam, The Netherlands.
Abstract
RATIONALE: There is a substantial unmet need for biomarkers to predict treatment response in major depressive disorder (MDD). Evidence has converged on activation of the inflammatory response system as a fundamental mechanism underlying MDD. OBJECTIVES: By investigating circulating leukocyte subsets quantified by fluorescence-activated cell sorting (FACS) analysis before treatment, we aim to predict antidepressant response. METHODS: Forty medication-free inpatients with melancholic, non-psychotic depression before treatment with either venlafaxine or imipramine and 40 age- and gender-matched healthy controls were included. Leukocyte subsets were quantified by FACS analysis using frozen peripheral blood mononuclear cells (PBMC) collected prior to and after 7 weeks of treatment with either venlafaxine (375 mg/day) or imipramine (blood level 200-300 ng/ml). Response was defined as at least 50 % reduction of the baseline Hamilton Rating Scale for Depression (HAM-D) score. RESULTS: Prior to treatment, MDD patients showed reduced percentages of CD4(+)CD25(high)Foxp3(+) T regulatory (Treg) cells when compared with controls (1.5 ± 0.6 vs. 1.8 ± 0.6, p = .037). After treatment, robust rises in Treg cells were observed in patients (1.8 ± 0.7, p < .001), yet Treg cells were not predictors of the clinical outcome of treatment. Antidepressant non-responders showed increased CD8(+) cytotoxic T cell percentages (24.0 ± 8.6 vs. 15.9 ± 5.9, p = .004) and decreased natural killer (NK) cell percentages (14.0 ± 6.9 vs. 21.4 ± 11.9, p = .020) compared with responders before treatment. Both lymphocyte levels were not significantly modulated by treatment. CONCLUSION: In melancholic MDD, FACS analysis of circulating leukocyte subpopulations might help to discriminate between patients with high or low responsiveness to antidepressant treatment.
RATIONALE: There is a substantial unmet need for biomarkers to predict treatment response in major depressive disorder (MDD). Evidence has converged on activation of the inflammatory response system as a fundamental mechanism underlying MDD. OBJECTIVES: By investigating circulating leukocyte subsets quantified by fluorescence-activated cell sorting (FACS) analysis before treatment, we aim to predict antidepressant response. METHODS: Forty medication-free inpatients with melancholic, non-psychotic depression before treatment with either venlafaxine or imipramine and 40 age- and gender-matched healthy controls were included. Leukocyte subsets were quantified by FACS analysis using frozen peripheral blood mononuclear cells (PBMC) collected prior to and after 7 weeks of treatment with either venlafaxine (375 mg/day) or imipramine (blood level 200-300 ng/ml). Response was defined as at least 50 % reduction of the baseline Hamilton Rating Scale for Depression (HAM-D) score. RESULTS: Prior to treatment, MDDpatients showed reduced percentages of CD4(+)CD25(high)Foxp3(+) T regulatory (Treg) cells when compared with controls (1.5 ± 0.6 vs. 1.8 ± 0.6, p = .037). After treatment, robust rises in Treg cells were observed in patients (1.8 ± 0.7, p < .001), yet Treg cells were not predictors of the clinical outcome of treatment. Antidepressant non-responders showed increased CD8(+) cytotoxic T cell percentages (24.0 ± 8.6 vs. 15.9 ± 5.9, p = .004) and decreased natural killer (NK) cell percentages (14.0 ± 6.9 vs. 21.4 ± 11.9, p = .020) compared with responders before treatment. Both lymphocyte levels were not significantly modulated by treatment. CONCLUSION: In melancholic MDD, FACS analysis of circulating leukocyte subpopulations might help to discriminate between patients with high or low responsiveness to antidepressant treatment.
Entities:
Keywords:
Antidepressants; Cytotoxic T cells; Fluorescence-activated cell sorting; Major depressive disorder; Natural killer cells; T regulatory cells; Treatment reponse
Authors: Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava Journal: Am J Psychiatry Date: 2006-01 Impact factor: 18.112
Authors: Andrea C Samson; Eva Meisenzahl; Johanna Scheuerecker; Emma Rose; Veronika Schoepf; Martin Wiesmann; Thomas Frodl Journal: J Psychiatr Res Date: 2011-04-07 Impact factor: 4.791
Authors: Katherine E Tansey; Michel Guipponi; Nader Perroud; Guido Bondolfi; Enrico Domenici; David Evans; Stephanie K Hall; Joanna Hauser; Neven Henigsberg; Xiaolan Hu; Borut Jerman; Wolfgang Maier; Ole Mors; Michael O'Donovan; Tim J Peters; Anna Placentino; Marcella Rietschel; Daniel Souery; Katherine J Aitchison; Ian Craig; Anne Farmer; Jens R Wendland; Alain Malafosse; Peter Holmans; Glyn Lewis; Cathryn M Lewis; Tine Bryan Stensbøl; Shitij Kapur; Peter McGuffin; Rudolf Uher Journal: PLoS Med Date: 2012-10-16 Impact factor: 11.069
Authors: Holly Green; Xiaoqun Zhang; Katarina Tiklova; Nikolaos Volakakis; Lovisa Brodin; Louise Berg; Paul Greengard; Thomas Perlmann; Per Svenningsson Journal: Proc Natl Acad Sci U S A Date: 2017-01-30 Impact factor: 11.205
Authors: Daniel C McFarland; Devika R Jutagir; Andrew H Miller; William Breitbart; Christian Nelson; Barry Rosenfeld Journal: J Natl Compr Canc Netw Date: 2020-04 Impact factor: 11.908
Authors: Hideo Suzuki; Jonathan Savitz; T Kent Teague; Siva K Gandhapudi; Chibing Tan; Masaya Misaki; Brett A McKinney; Michael R Irwin; Wayne C Drevets; Jerzy Bodurka Journal: Brain Behav Immun Date: 2017-06-20 Impact factor: 7.217
Authors: Shariful A Syed; Eléonore Beurel; David A Loewenstein; Jeffrey A Lowell; W Edward Craighead; Boadie W Dunlop; Helen S Mayberg; Firdaus Dhabhar; W Dalton Dietrich; Robert W Keane; Juan Pablo de Rivero Vaccari; Charles B Nemeroff Journal: Neuron Date: 2018-08-23 Impact factor: 17.173
Authors: Stefan O Reber; Philip H Siebler; Nina C Donner; James T Morton; David G Smith; Jared M Kopelman; Kenneth R Lowe; Kristen J Wheeler; James H Fox; James E Hassell; Benjamin N Greenwood; Charline Jansch; Anja Lechner; Dominic Schmidt; Nicole Uschold-Schmidt; Andrea M Füchsl; Dominik Langgartner; Frederick R Walker; Matthew W Hale; Gerardo Lopez Perez; Will Van Treuren; Antonio González; Andrea L Halweg-Edwards; Monika Fleshner; Charles L Raison; Graham A Rook; Shyamal D Peddada; Rob Knight; Christopher A Lowry Journal: Proc Natl Acad Sci U S A Date: 2016-05-16 Impact factor: 11.205